title: Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer.
authors: Ainhoa
authors: A
authors: Viteri
authors: Alberto
authors: A
authors: Muñoz
authors: Itziar
authors: I
authors: Rubio
authors: Ramón
authors: R
authors: Barceló
authors: Alejandro
authors: A
authors: Martínez-Bueno
authors: Ricardo
authors: R
authors: Fernández
authors: Sergio
authors: S
authors: Carrera
authors: Guillermo
authors: G
authors: López-Vivanco
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000069287:Capecitabine; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004943:Esophagogastric Junction / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D013274:Stomach Neoplasms / Q000188:drug therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D003841:Deoxycytidine; D000069287:Capecitabine; D002945:Cisplatin; D005472:Fluorouracil